Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRF vs OnabotulinumtoxinA in Chronic Migraine
NCT07837570Phase 4Not yet recruiting
- Sponsor
- Assiut University
- Start
- Oct 2026
- Primary completion
- Oct 2027
01
Overview
Phase 4, randomised trial of botulinum toxin type A in chronic migraine (2 arms), sponsored by Assiut University. Primary endpoint: Change in the mean number of monthly migraine days at 24 weeks. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
chronic migraine
Beyond the preview
Go deeper on NCT07837570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07837570.